FYERS
iSERA Lifesciences 143.90
+0.00 (+0.00%)

iSERA Lifesciences Share Price

143.90+0.00 (+0.00%)
+1868.21% past 1 Year

Corporate filings & documents

Announcements

We hereby submit the copy of Newspaper Publication of Public Notice regarding 34th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through VC/ OAVM .
2 weeks ago
We hereby submit the copy of Newspaper Publication of Public Notice regarding 34th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through VC/ OAVM .
2 weeks ago
we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financial year 2025-26
2 weeks ago
we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financial year 2025-26
2 weeks ago
Notice of 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through video conference (VC)/ other audio visual means (OAVM) in compliance with the applicable provisions of the Companies Act 2013 and rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and relevant circulars issued by MCA and SEBI.
2 weeks ago
Notice of 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through video conference (VC)/ other audio visual means (OAVM) in compliance with the applicable provisions of the Companies Act 2013 and rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and relevant circulars issued by MCA and SEBI.
2 weeks ago
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
2 weeks ago
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
2 weeks ago
We hereby informed that Board of Directors of the Company at its meeting held on Tuesday the 01st September 2026 discuss the agenda attached herewith.
3 weeks ago
We hereby informed that Board of Directors of the Company at its meeting held on Tuesday the 01st September 2026 discuss the agenda attached herewith.
3 weeks ago
We hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended June 30 2026.
1 month ago
We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month ago
We are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month ago
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Friday the 07th day of August 2026 at the Registered Office of the Company which commenced at 02:00 P.M.and concluded at 02:30 P.M. considered and approved inter alia to approve the Un-Audited Financial Results of the Company for the quarter ended June 30 2026.
1 month ago
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Friday the 07th day of August 2026 at the Registered Office of the Company which commenced at 02:00 P.M.and concluded at 02:30 P.M. considered and approved inter alia to approve the Un-Audited Financial Results of the Company for the quarter ended June 30 2026.
1 month ago
Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on June 30 2026
1 month ago
Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on June 30 2026
1 month ago
We are hereby submitting the Certificate issued by Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2026.
2 months ago
We are hereby submitting the Certificate issued by Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2026.
2 months ago
Scrutinizers Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26 2026.
2 months ago
Scrutinizers Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26 2026.
2 months ago
Submission of Newspaper Advertisement of Corrigendum to the Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 months ago
Submission of Newspaper Advertisement of Corrigendum to the Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 months ago
We wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh TechnologiesLimited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21 2026 videCorrigendum dated June 26 2026 in connection with the proposed preferential issue of equity shares forconsideration other than cash (Share Swap). The said Corrigendum has been dispatched to all Members ofthe Company as on the cut-off date i.e. Friday April 17 2026 on June 26 2026.A copy of the Corrigendum is enclosed herewith for your kind perusal and records.Kindly take the above on record.
2 months ago
We wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh TechnologiesLimited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21 2026 videCorrigendum dated June 26 2026 in connection with the proposed preferential issue of equity shares forconsideration other than cash (Share Swap). The said Corrigendum has been dispatched to all Members ofthe Company as on the cut-off date i.e. Friday April 17 2026 on June 26 2026.A copy of the Corrigendum is enclosed herewith for your kind perusal and records.Kindly take the above on record.
2 months ago
We are hereby submitting the Closure of Trading Window for the Quarter June 30 2026.
2 months ago
We are hereby submitting the Closure of Trading Window for the Quarter June 30 2026.
2 months ago
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as "Covidh Technologies Limited") was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
3 months ago
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as "Covidh Technologies Limited") was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
3 months ago
We hereby submit the Newspaper Advertisement for the financial result for the year and quarter ended March 31 2026
4 months ago
We hereby submit the Newspaper Advertisement for the financial result for the year and quarter ended March 31 2026
4 months ago
We are hereby submitting the Scrutinizers Report for the postal ballot.
4 months ago
We hereby submit the declaration w.r.t. non applicability of regulation 23(9) of SEBI LODR
4 months ago
We hereby submit the declaration w.r.t. non applicability of regulation 23(9) of SEBI LODR
4 months ago
Revised outcome of the board meeting for discussing and approving the financial results for the year ended 31.03.2026
4 months ago
Revised outcome of the board meeting for discussing and approving the financial results for the year ended 31.03.2026
4 months ago
We hereby Submitted the Financial Result for the Financial Year ended 31 March 2026
4 months ago
We hereby submitted Pursuant to the provisions of Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Thursday the 21st day of May 2026 held via video conferencing which commenced at 07:00 P.M. and concluded at 07:40 P.M. considered and approved inter-alia: 1. The Audited Financial Results (Standalone) for the Quarter and year ended 31st March 2026 in pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.2. Independent Auditors Report on Audited Financial Results (Standalone) of the Company for the quarter and year ended 31st March 2026.3. Declaration for unmodified opinion in terms of Regulation 33(3)(d) as amended by SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations 2016 for Audited Standalone Financial Results for the year ended on 31st March 2026.
4 months ago
We hereby submitted Pursuant to the provisions of Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Thursday the 21st day of May 2026 held via video conferencing which commenced at 07:00 P.M. and concluded at 07:40 P.M. considered and approved inter-alia: 1. The Audited Financial Results (Standalone) for the Quarter and year ended 31st March 2026 in pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.2. Independent Auditors Report on Audited Financial Results (Standalone) of the Company for the quarter and year ended 31st March 2026.3. Declaration for unmodified opinion in terms of Regulation 33(3)(d) as amended by SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations 2016 for Audited Standalone Financial Results for the year ended on 31st March 2026.
4 months ago
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)has filed with exchange monitoring agency report for quarter ended March 31 2026.
4 months ago
Monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended 31 March 2026.
4 months ago
Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31 2026
4 months ago
Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31 2026
4 months ago
Submission of Newspaper Advertisement of Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
5 months ago
Submission of Newspaper Advertisement of Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
5 months ago
Pursuant to the resolution passed by the Board of Directors of the Company at its meeting held on Tuesday April 21 2026 the Company encloses herewith the Postal Ballot Notice dated April 21 2026 seeking the approval of the Members of the Company by way of Postal Ballot / Remote E-Voting on the following matters
5 months ago
Revised Outcome of the Meeting of the Board of Directors of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) (the Company) pursuant to Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
5 months ago
ISSUANCE OF EQUITY SHARES BY WAY OF PREFERENTIAL ISSUE ON PRIVATE PLACEMENT BASIS FOR CONSIDERATION OTHER THAN CASH (SHARE SWAP)
5 months ago
ISSUANCE OF EQUITY SHARES BY WAY OF PREFERENTIAL ISSUE ON PRIVATE PLACEMENT BASIS FOR CONSIDERATION OTHER THAN CASH (SHARE SWAP)
5 months ago
The Board of Directors considered and approved the increase in the Authorised Share Capital of the Company from Rs. 11 00 00 000/- (Rupees Eleven Crore Only) divided into 1 10 00 000 (One Crore Ten Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 25 00 00 000/- (Rupees Twenty-Five Crore Only) divided into 2 50 00 000 (Two Crore Fifty Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each by creation of 1 40 00 000 (One Crore Forty Lakh) additional Equity Shares of Rs. 10/- (Rupees Ten Only) each and the consequential alteration of Clause V of the Memorandum of Association of the Company subject to the approval of the Members of the Company by way of an Ordinary Resolution through Postal Ballot / Remote E-Voting pursuant to Section 110 of the Companies Act 2013 read with Rule 22 of the Companies (Management and Administration) Rules 2014.
5 months ago

Annual reports

FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

iSERA Lifesciences Ltd Share Price Today

The iSERA Lifesciences Ltd share price today is ₹143.90. During the trading session, the iSERA Lifesciences Ltd share price opened at ₹0.00 and recorded an intraday high of ₹0.00 and a low of ₹0.00. Last closing price was ₹143.90. Over the past 52 weeks, the iSERA Lifesciences Ltd share price has ranged between ₹6.17 and ₹143.90. The current iSERA Lifesciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.